Categories Health Care

Moderna (MRNA) ships coronavirus vaccine candidate for trials, shares hit a peak

Shares of Moderna Inc. (NASDAQ: MRNA) soared to a record high of $29.98 on Wednesday after shipping the first coronavirus vaccine candidate to the National Institutes of Health for clinical trials. However, market experts remain concerned over the time required for the vaccine to reach the public, even if it clears the trials.

In January, the company announced a collaboration to develop a coronavirus vaccine following a positive phase 1 data readout for the cytomegalovirus (CMV) vaccine. The company has shifted its focus towards the coronavirus. Moderna expects the initial clinical trial to start by late April with the drug’s efficacy results likely to be available by July or August.

vaccine syringe and vial
Image for representation. Courtesy: CDC on Unsplash

Quarterly Performance

For the fourth quarter, Moderna reported a narrower loss helped by lower operating expenses. The top line dropped by 60% due to lower collaboration revenue across all strategic alliances, particularly AstraZeneca and Merck. Research and development expenses fell by 21% due to a decrease in in-licensing payments to Cellscript, LLC and its affiliate, and a reduction of lab supplies and materials costs.

As of December 31, 2019, the company had total cash of $1.26 billion while the total debt stood at $33.8 million. The company has up to $2 billion to invest, including cash and investments, financing proceeds and potentially available grants.

Till now, Moderna does not have any approved vaccines or treatments but currently has 24 messenger RNA development candidates in its portfolio with 12 in clinical studies. The company is likely to be beneficial in the future as there is no approved vaccine for novel coronavirus.

Stock Movement

The stock has been trading between $11.54 and $29.98 in the past 52 weeks. The shares are above the 50-day moving average of $20.34 and the 200-day moving average of $17.84. The shares have risen over 104% in the past six months as investors remained positive about the clinical-stage biotech company’s future growth prospects.

Read: Intercept Pharmaceuticals Q4 earnings snapshot

The market analysts were bullish on the stock with an average price target of $29.25. The investors and institutional funds have taken the tip from the analysts as the three-month average share volume of 4.5 million has risen to 14.56 million of average volume for 10 days. The demand for the stock keeps on increasing.

Global Pandemic

China has reported a slump in the new cases but a sudden rise in cases in South Korea and Italy made it a global pandemic. Globally, there were more than 81,000 confirmed cases of coronavirus with South Korea remaining the worst affected outside China.

The stock market has been feeling the pressure from the coronavirus outbreak. On Tuesday, the stocks ended lower for the fourth straight day, which was sparked by the rising number of cases outside of China.

The Centers for Disease Control and Prevention (CDC) on Tuesday labeled the virus as a “serious public health threat” as it is likely to spread to the US. The public health officials warn Americans about potential disruption if the virus starts spreading and suggests asking schools and workplaces about contingency plans.

We’re on Apple News! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

Darden Restaurants (DRI) Q4 2024 Earnings: Key financials and quarterly highlights

Darden Restaurants, Inc. (NYSE: DRI) reported fourth quarter 2024 earnings results today. Total sales increased 6.8% year-over-year to $2.95 billion. Same-restaurant sales remained flat.   Net earnings were $308.1 million,

KR Earnings: Kroger Q1 sales and profit top expectations

Grocery chain The Kroger Co. (NYSE: KR) reported a decline in adjusted profit for the first quarter of 2024, despite a modest increase in net sales. The results exceeded Wall Street's

ACN Earnings: Key quarterly highlights from Accenture’s Q3 2024 financial results

Accenture (NYSE: ACN) reported its third quarter 2024 earnings results today. Revenues were $16.5 billion, down 1% in US dollars and up 1.4% in local currency compared to the third

Comments

  1. Pingback: Faculty expertise
  2. Pingback: Politics
  3. Pingback: Dental services
  4. Pingback: MBA tuition fees
  5. Pingback: fue
  6. Pingback: pharmacists
  7. Pingback: IT Professionals
  8. Pingback: faculty of dental
  9. Pingback: cage mma
  10. Pingback: Fiverr Earn
  11. Pingback: fiverrearn.com
  12. Pingback: fiverrearn.com
  13. Pingback: fiverrearn.com
  14. Pingback: fiverrearn.com
  15. Pingback: fluffy frenchies
  16. Pingback: dog kennel
  17. Pingback: chiweenie dog
  18. Pingback: seo in Greece
  19. Pingback: isla mujeres
  20. Pingback: best mobile phone
  21. Pingback: FiverrEarn
  22. Pingback: Fiverr.Com
  23. Pingback: fue
  24. Pingback: Warranty
  25. Pingback: FUE
  26. Pingback: FUE
  27. Pingback: FUE
  28. Pingback: FUE
  29. Pingback: FUE
  30. Pingback: FUE
  31. Pingback: Packing expertise
  32. Pingback: Moving assistance
  33. Pingback: Classic Books 500
  34. Pingback: FiverrEarn
  35. Pingback: FiverrEarn
  36. Pingback: FiverrEarn
  37. Pingback: Speaker
  38. Pingback: partners
  39. Pingback: java burn reviews
  40. Pingback: FiverrEarn
  41. Pingback: FiverrEarn
  42. Pingback: FiverrEarn
  43. Pingback: FiverrEarn
  44. Pingback: live sex cams
  45. Pingback: live sex cams
  46. Pingback: FiverrEarn
  47. Pingback: FiverrEarn
  48. Pingback: FiverrEarn
  49. Pingback: FiverrEarn
  50. Pingback: FiverrEarn
  51. Pingback: FiverrEarn
  52. Pingback: FiverrEarn
  53. Pingback: FiverrEarn
  54. Pingback: FiverrEarn
  55. Pingback: FiverrEarn
  56. Pingback: FiverrEarn
  57. Pingback: FiverrEarn
  58. Pingback: serialebi qaerulad
  59. Pingback: Food
  60. Pingback: web design
  61. Pingback: Slot Online
  62. Pingback: FiverrEarn
  63. Pingback: FiverrEarn
  64. Pingback: cheap sex cams
  65. Pingback: Freeze dried water
  66. Pingback: rare breed-trigger
  67. Pingback: App Designing
  68. Pingback: 늑대닷컴
  69. Pingback: Bonus free spin
  70. Pingback: nangs sydney
  71. Pingback: superslot
  72. Pingback: allgame
  73. Pingback: 918kiss
  74. Pingback: หวย24
  75. Pingback: pg slot
  76. Pingback: evisa
  77. Pingback: sicarios madrid
  78. Pingback: Skywhip tanks
  79. Pingback: Plombier Tours
  80. Pingback: itsmasum.com
  81. Pingback: emerald chat
  82. Pingback: talkwithstranger
  83. Pingback: itsmasum.com
  84. Pingback: itsmasum.com
  85. Pingback: newyorkcareerhub
  86. Pingback: talent search
  87. Pingback: chicago job search

Comments are closed.

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top